198 related articles for article (PubMed ID: 35651609)
21. An Update on Syndromes with a Hyper-IgE Phenotype.
Bergerson JRE; Freeman AF
Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
[TBL] [Abstract][Full Text] [Related]
22. Atopic dermatitis or hyper-IgE syndrome?
Ohameje NU; Loveless JW; Saini SS
Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
[TBL] [Abstract][Full Text] [Related]
23. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
24. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
25. [Hyper IgE syndrome: atopic dermatitis as first manifestation. Case report].
Carrera Dangond MM; Schellnast Faure A; Fernanda Vargas M; Regairaz L; Cabanillas D
Arch Argent Pediatr; 2021 Aug; 119(4):e370-e374. PubMed ID: 34309321
[TBL] [Abstract][Full Text] [Related]
26. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
27. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
[TBL] [Abstract][Full Text] [Related]
28. Hyper-IgE syndrome, 2021 update.
Minegishi Y
Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
[TBL] [Abstract][Full Text] [Related]
29. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
[TBL] [Abstract][Full Text] [Related]
30. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.
Belaid B; Lamara Mahammed L; Mohand Oussaid A; Migaud M; Khadri Y; Casanova JL; Puel A; Ben Halla N; Djidjik R
Front Immunol; 2021; 12():696350. PubMed ID: 34248995
[TBL] [Abstract][Full Text] [Related]
32. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.
Ohga S; Nomura A; Ihara K; Takahata Y; Suga N; Akeda H; Shibata R; Okamura J; Kinukawa N; Hara T
Br J Haematol; 2003 Apr; 121(2):324-31. PubMed ID: 12694256
[TBL] [Abstract][Full Text] [Related]
33. Hyper IgE in Childhood Eczema and Risk of Asthma in Chinese Children.
Ng C; Hon KL; Kung JS; Pong NH; Leung TF; Wong CK
Molecules; 2016 Jun; 21(6):. PubMed ID: 27294900
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous manifestations of DOCK8 deficiency syndrome.
Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
[TBL] [Abstract][Full Text] [Related]
35. Selective loss of function variants in
Shahin T; Aschenbrenner D; Cagdas D; Bal SK; Conde CD; Garncarz W; Medgyesi D; Schwerd T; Karaatmaca B; Cetinkaya PG; Esenboga S; Twigg SRF; Cant A; Wilkie AOM; Tezcan I; Uhlig HH; Boztug K
Haematologica; 2019 Mar; 104(3):609-621. PubMed ID: 30309848
[TBL] [Abstract][Full Text] [Related]
36. Treatment options for DOCK8 deficiency-related severe dermatitis.
Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
[TBL] [Abstract][Full Text] [Related]
37. Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency.
Liquidano-Perez E; Maza-Ramos G; Perez Arias BA; Lugo Reyes SO; Barragan Arevalo T; Solorzano-Morales SA; Venegas Montoya E; Staines-Boone AT; Guzmán Cotaya R; Okada S; Picard C; Patin E; Ramirez-Uribe N; Bustamante-Ogando JC; Scheffler-Mendoza SC; Yamazaki-Nakashimada MA; Saez-de-Ocariz M; Espinosa Padilla SE; Gonzalez-Serrano ME
Pediatr Allergy Immunol; 2024 Feb; 35(2):e14073. PubMed ID: 38351896
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
[TBL] [Abstract][Full Text] [Related]
39. Elevated IgE Levels-An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
Kostova P; Papochieva V; Miteva D; Georgieva B; Mileva S; Shahid M; Lukanov T; Petrova G
Antibodies (Basel); 2023 Nov; 12(4):. PubMed ID: 37987248
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome.
Lévy R; Béziat V; Barbieux C; Puel A; Bourrat E; Casanova JL; Hovnanian A
J Clin Immunol; 2020 Feb; 40(2):418-420. PubMed ID: 31993867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
